Subscribe

What are you looking for?

Main Menu

明報新聞網

施政報告2025丨李氏大藥廠冀加快「1+」新藥審批機制

Future Wealths
Future Wealths
17 9 月, 2025
One Min Read
9 Views
0 Comments
李氏大藥廠（0950）就《施政報告》表示，公司支持政府擬2026年內成立國際認可的藥械權威監管機構「香港藥物及醫療器械監督管理中心」，歡迎吸引更多國際和內地頂尖藥企落戶香港。

原文: https://finance.mingpao.com/fin/instantf/20250917/1758100063640/%e6%96%bd%e6%94%bf%e5%a0%b1%e5%91%8a2025%e4%b8%a8%e6%9d%8e%e6%b0%8f%e5%a4%a7%e8%97%a5%e5%bb%a0%e5%86%80%e5%8a%a0%e5%bf%ab%e3%80%8c1-%e3%80%8d%e6%96%b0%e8%97%a5%e5%af%a9%e6%89%b9%e6%a9%9f%e5%88%b6

Last Update: 17 9 月, 2025

Please share this article if you like it!

Link Copied!
Future Wealths
Written By

Future Wealths

Other Articles

Related Posts

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept